All In MedTech

Device Trial Radar · NCT03752151

Micra Atrial TRacking Using A Ventricular AccELerometer 2

Last checked: Nov 19, 2026Latest source record: Jun 4, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

77

Actual

Start

Jan 22, 2019

Primary completion

Aug 7, 2019

Study completion Aug 7, 2019

Sponsor

Sponsor type
Industry
First posted
Nov 23, 2018

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the Micra Atrial TRacking Using A Ventricular AccELerometer 2 (MARVEL 2) study is to demonstrate safe and effective operation of the MARVEL 2 features for providing AV synchronous pacing in patients with normal sinus node function and AV block

Conditions

  • Atrioventricular Conduction Block

Interventions

  • MARVEL 2 Algorithm Monitor Mode then Adaptive ModeDevice

    Software download into implanted Micra device and programmed to MARVEL 2 Monitor Mode then MARVEL 2 Adaptive Mode

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Atrial Ventricular Pacing Synchrony Success During RestTime frame: 40 Minutes
  2. Number of Participants Free From Inappropriate Pacemaker Function EventsTime frame: Through study completion an average of one day

Locations

12 sites in 8 countries. Site status is shown where the registry gives one.

  • Baptist Medical Center Jacksonville

    Jacksonville, Florida

  • Baptist Hospital

    Miami, Florida

  • North Shore University Hospital- Northwell

    Manhasset, New York

9 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.